Hydrochloric Acid → HCID 178480925, compound
Reaction equation
Cl.C(OC(=O)[NH:8][C@H:9]1[CH2:14][CH2:13][C@H:12]([NH:15][C:16](=[O:25])[CH2:17][N:18]2[CH2:23][CH2:22][N:21]([CH3:24])[CH2:20][CH2:19]2)[CH2:11][CH2:10]1)(C)(C)C.CCOCC>CO>[NH2:8][C@H:9]1[CH2:10][CH2:11][C@H:12]([NH:15][C:16](=[O:25])[CH2:17][N:18]2[CH2:19][CH2:20][N:21]([CH3:24])[CH2:22][CH2:23]2)[CH2:13][CH2:14]1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
An aqueous solution of HCl (2 M, 15 mL) was added to a solution of trans-{4-[2-(4-methyl-piperazin-1-yl)-acetylamino]-cyclohexyl}-carbamic acid tert-butyl ester (199 mg, 0.56 mmol) in MeOH (15 mL) at RT, and the resulting mixture was stirred overnight. The reaction mixture was concentrated under reduced pressure to give a solid residue. Et2O was added to this material, and the resulting suspension was sonicated. The ether phase was decanted away, leaving a powdery brown solid which was purified by preparative TLC. The resulting oil was dissolved in the minimum quantity of MeOH, and Et2O was added. A solid precipitated; the liquid phase was decanted away to give, after drying, 75 mg of trans-N-(4-amino-cyclohexyl)-2-(4-methyl-piperazin-1-yl)-acetamide as a fine powder.
Workup
- concentrationThe reaction mixture was concentrated under reduced pressure
- customto give a solid residue
- customthe resulting suspension was sonicated
- customThe ether phase was decanted away
- customleaving a powdery brown solid which
- customwas purified by preparative TLC
- dissolutionThe resulting oil was dissolved in the minimum quantity of MeOH, and Et2O
- additionwas added
- customA solid precipitated
- customthe liquid phase was decanted away
- customto give
- customafter drying
Sources & evidence
- ORD record
- ord-9447c1ba99b44f1c87d452cbae8b3f1d
- Source dataset
- uspto-grants-2015_02
- Patent number
- US08962622B2
Reaction notes
Loading…